Build a company that can produce useful results early
Proposed strategy. A credible first company would focus on research tools for neural-model characterization and injury-related studies. Candidate outputs include recording workflows, quality-control software, documented analysis pipelines, and carefully scoped research collaborations. Each is a proposal requiring customer discovery and technical validation. No customers, partnerships, patents, clinical approvals, revenue, or laboratory capability are claimed on this page.
Proposed strategy. This page expands the “Build a company that can produce useful results early” chapter in the neuroscience collection.
A credible first company would focus on research tools for neural-model characterization and injury-related studies. Candidate outputs include recording workflows, quality-control software, documented analysis pipelines, and carefully scoped research collaborations. Each is a proposal requiring customer discovery and technical validation. No customers, partnerships, patents, clinical approvals, revenue, or laboratory capability are claimed on this page.
Begin with interviews across three groups: academic laboratories that struggle with repeatable neural recordings, device teams that need well-characterized biological test systems, and translational researchers who need interpretable model data. Ask what decision the result would change, what workflow is already used, where it fails, and whether independent replication would make the output useful. A compelling scientific story is not evidence of demand.
Select one narrow initial deliverable. Define the sample type, instrument compatibility, output format, turnaround constraints, and acceptance criteria before selling it. If the first offering is software, identify which results remain the customer’s responsibility. If it involves laboratory services, establish genuine operational capacity and the appropriate institutional arrangements before accepting work. An early contract should purchase an actual deliverable in bona fides, not proximity to a resurrection narrative.
Protect long-horizon research by avoiding dependence on impossible product promises. Financing should support a specified work package, with costs grounded in facility access, personnel, equipment, quality systems, and the ability to repeat failures. The proposed model reserves resources for foundational research while seeking nearer-term value from methods that other scientists can inspect. A negative result should remain publishable and financially survivable.
Open this exact section in the Necromancer dossier. The original chapter status is “Proposed strategy.”
Take this topic further
Turn “Build a company that can produce useful results early” into a learning path
The Learning Studio will use this page’s overview and key ideas to shape a guided lesson, practice questions, and a small project around what you want to understand.
Related GiveGigs pages and features
Explore connected GiveGigs pages and tools for context and next steps.